Related by context. Frequent words. (Click for all words.) 65 targeted immunotherapies 62 Canvaxin 61 oncolytic virus therapies 61 thetreatment 61 novel antibody therapeutics 61 Æterna Zentaris Inc. 61 Taiho Pharmaceutical 61 colorectal lung 60 urinary bladder wall 60 metastatic renal cell 60 oncology infectious diseases 60 TSX AEZ 59 refractory chronic lymphocytic 59 oral deforolimus 59 immuno inflammatory diseases 59 Inc. Nasdaq INFI 59 Dacetuzumab 59 Masimo NASDAQ MASI 58 NASDAQ IMCL 58 sorafenib tablets 58 gastrointestinal mucositis 58 Currently RegeneRx 58 motesanib 58 efficient thermoelectric TE 58 MKC# MT 58 ZALBIN 58 See BioWorld Today 58 inflammatory autoimmune diseases 58 Nexavar sorafenib 58 ThermoDox R 58 PRNewswire FirstCall YM BioSciences 58 human antibody therapeutics 58 Japanese drugmaker Daiichi 57 ® bortezomib 57 ZFP Therapeutics 57 metastatic colorectal 57 commercializing therapeutic 57 R sorafenib tablets 57 CPL Biologicals 57 therapeutic monoclonal antibodies 57 commercialize phytocannabinoid based 57 By BEVERLY CORBELL 57 Galderma SA 57 Roche SIX RO 57 addressing idiopathic pulmonary 56 Pavarotti underwent surgery 56 Crucell NV NYSE Euronext 56 CDP# 56 DELATESTRYL R 56 BioNumerik 56 Lupuzor 56 forodesine 56 Nasdaq CRXL 56 Asentar 56 ankylosing spondylitis psoriatic arthritis 56 lymphoma leukemia 56 CytoFab 56 By DANIE HARRELSON 56 TRAIL receptor antibodies 56 Nasdaq ALNY 56 pemphigus vulgaris 56 Nasdaq VRTX 56 Biological Therapy 56 based pretargeting methods 56 Holding AG ROG.VX 55 cardio renal 55 Onalta 55 AEG# 55 ovarian breast 55 lung pancreatic 55 Allovectin 7 55 Bioenvision compounds under 55 Phase Ib IIa 55 produces Chrysler Jeep 55 PNP inhibitor 55 Belimumab 55 hepatitis C HCV 55 Crucell NV Euronext 55 OGeS 55 Inc. NASDAQ BIOC 55 Completes Patient Enrollment 55 By Amy Boerema 55 candidates bavituximab 55 VEGFR2 inhibitor 55 organ transplant rejection 55 Merck discovers develops 55 By EILEEN SMITH 55 Vytorin combines 55 QUALCOMM Incorporated http:/www.qualcomm.com/ 55 RNA interference RNAi therapeutics 55 Nasdaq OSIP 54 RhuDex ® 54 AEterna Zentaris Inc. 54 immunotherapeutics 54 TaiGen 54 neuro inflammatory 54 Initiates Phase II 54 endocrine diseases 54 Archemix Corp. 54 coagulation disorders 54 HIV protease inhibitor Lexiva